Procter & Gamble Health block deals, bulk deals, insider trading and stake changes
NSE: PGHLBSE: 500126Pharmaceuticals & BiotechnologySmall Cap
Formerly Merck
Last close ₹5,015.00down ₹47.50 (0.94%)BSE ₹5,032.75
Share price at the NSE close on 23 Oct 2026. Previous close ₹5,062.50.
52-week range of traded prices to 23 Oct 2026
₹4,707.00Low, 6 Apr 2026₹6,975.00High, 15 Jul 2026
- Next results date: the board meets on 2 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹8,325 Cr585th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 6 Aug 2026
- 23.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 15.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 4.09%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 6 Aug 2026
- 67.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- 84.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 18,32148.9% delivered
Procter & Gamble Health insider trading
All 4 disclosures on record. The company's own latest disclosure on record is from Dec 2018.Insider trading, all companies
Dec 2018
- Procter & Gamble Overseas India B. V.₹1,290 Cr86,01,071 sharesReceived · Promoters · 3 Dec 2018 · disclosed 10 Dec · Off Market · holds 86,01,071 after, stake 51.81% after
- CHEMITRA GESELLSCHAFT MIT BESCHRANKTER HAFTUNG₹296 Cr19,73,441 sharesGave · Promoter Group · 3 Dec 2018 · Off Market · held 19,73,441 before
- MERCK INTERNATIONALE BETEILIGUNGEN GMBH₹464 Cr30,91,224 sharesGave · Promoter Group · 3 Dec 2018 · Off Market · held 30,91,224 before
- Emedia Export Company Mit Beschrankter Haftung₹530 Cr35,34,559 sharesGave · Promoter Group · 3 Dec 2018 · Off Market · held 35,34,559 before
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Procter & Gamble Health stake sales and purchases
1 disclosure on record.
Apr 2021
- SoldLife Insurance Corporation of India2.00% of the company3,32,072 sharesholds 3.82% after29 Apr 2021 · filed under the 2% rule
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Procter & Gamble Health block deals and bulk deals
None in the last 12 months, since 23 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Monday 3 Oct 20224 firms · ₹21 Cr bought · ₹21 Cr soldNet nil
- SoldISHARES CORE EMERGING MARKETS MAURITIUS COBlock dealSold 44,711 at ₹4,106.950.27% of the company₹18 Cr
- BoughtISHARES CORE MSCI EMERGING MARKETS ETFBlock dealBought 44,711 at ₹4,106.950.27% of the company₹18 Cr
- SoldISHARES INDIA SC MAURITIUS COMPANYBlock dealSold 6,405 at ₹4,106.950.04% of the company₹2.63 Cr
- BoughtISHARES MSCI INDIA SMALL-CAP ETFBlock dealBought 6,405 at ₹4,106.950.04% of the company₹2.63 Cr
Monday 19 Sep 20224 firms · ₹11 Cr bought · ₹11 Cr soldNet nil
- SoldISHARES CORE EMERGING MARKETS MAURITIUS COBlock dealSold 23,964 at ₹4,147.500.14% of the company₹9.94 Cr
- BoughtISHARES CORE MSCI EMERGING MARKETS ETFBlock dealBought 23,964 at ₹4,147.500.14% of the company₹9.94 Cr
- SoldISHARES INDIA SC MAURITIUS COMPANYBlock dealSold 3,433 at ₹4,147.500.02% of the company₹1.42 Cr
- BoughtISHARES MSCI INDIA SMALL-CAP ETFBlock dealBought 3,433 at ₹4,147.500.02% of the company₹1.42 Cr
Monday 13 Jan 20143 firms · ₹14 Cr bought · ₹14 Cr soldNet bought ₹83,997
- BoughtRELIANCE MUTUAL FUND A/C RELIANCE PHARMA FUNDBought 2,56,500 at ₹549.001.55% of the company₹14 Cr
- SoldAMERICAN FUND INSURANCE A/C AMERICAN INSURANCE SERIES GLOBALSold 1,41,849 at ₹549.000.85% of the company₹7.79 Cr
- SoldSMALLER CAP WORLD FUND INCSold 1,14,498 at ₹549.000.69% of the company₹6.29 Cr
Wednesday 6 Oct 20102 firms · ₹18 Cr bought · ₹18 Cr soldNet nil
- SoldHDFC MUTUAL FUND AC HDFC MONTHLY INCOME PLAN LONG TERMSold 2,48,994 at ₹730.001.50% of the company₹18 Cr
- BoughtSBI MUTUAL FUND AC MAGNUM SECTOR FUND UMBRELLA CONTRABought 2,49,000 at ₹729.981.50% of the company₹18 Cr
Friday 16 Oct 20092 firms · ₹13 Cr bought · ₹6.19 Cr soldNet bought ₹7.28 Cr
- BoughtHDFC TRUSTEE CO.LTD A/C HDFC MUTUAL FUND-MIP LONG TERM PLANBought 1,00,353 at ₹570.730.60% of the company₹5.73 Cr
- Both waysJMP SECURITIES PVT LTDBought 1,31,735 at ₹587.25Sold 1,05,340 at ₹587.160.78% of the companyNet +26,395 shares₹7.74 Cr bought
Wednesday 6 May 20092 firms · ₹10 Cr bought · ₹10 Cr soldNet nil
- BoughtAMERICAN FUNDS INSURANCE SERIESGLOBAL CAPITALIZATION FUNDBought 3,00,000 at ₹347.491.78% of the company₹10 Cr
- SoldHDFC MUTUAL FUNDSold 3,00,000 at ₹347.491.78% of the company₹10 Cr
Wednesday 20 Dec 20062 firms · ₹18 Cr bought · ₹14 Cr soldNet bought ₹3.21 Cr
- Both waysTEMPLETON MUTUAL FUND AC FRANKLBought 4,01,882 at ₹440.00Sold 98,901 at ₹440.00Net +3,02,981 shares₹18 Cr bought
- SoldFRANKLIN TEMPLETON INVESTMENT FSold 2,29,948 at ₹440.00₹10 Cr
Monday 21 Nov 20052 firms · ₹5.50 Cr bought · ₹4.95 Cr soldNet bought ₹0.55 Cr
- BoughtBSMA LTDBought 1,25,000 at ₹440.00₹5.50 Cr
- SoldMACKERTICH CONSULTANCY SERVICES PVT LTDSold 1,12,500 at ₹440.01₹4.95 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 18 deals on record from 4 Jan 2004.